This inventor holds 7 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignees: Council of Scientific and Industrial Research, Foundation for Neglected Disease Research (Fndr), National Centre for Polar and Ocean Research (Ncpor). Active years: 2011-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mumbai, IN (2011 - 2019)
- Jammu, IN (2018 - 2020)
Company Filing History:
4 out of 2,130 
1 out of 1 
1 out of 1 
Years Active: 2011-2020
Title: Girish Badrinath Mahajan: Innovator in Pharmaceutical Chemistry
Introduction
Girish Badrinath Mahajan is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with medicinal applications. With a total of seven patents to his name, Mahajan's work focuses on innovative solutions for health-related challenges.
Latest Patents
Among his latest patents, Mahajan has developed fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitors. This invention relates to specific compounds that can inhibit PI3Kα, which has potential medicinal uses as anticancer agents. Another significant patent involves antibiotic compounds, where he describes purified compounds that include all stereoisomeric and tautomeric forms. These compounds are produced through fermentation processes and are aimed at treating and preventing diseases caused by bacterial infections.
Career Highlights
Throughout his career, Mahajan has worked with esteemed organizations such as the Council of Scientific & Industrial Research and the National Centre for Polar and Ocean Research. His experience in these institutions has allowed him to contribute to various research projects and innovations in the field of pharmaceuticals.
Collaborations
Some of his notable coworkers include Ram Asrey Vishwakarma and Dilip Manikrao Mondhe. Their collaborative efforts have further advanced the research and development of new medicinal compounds.
Conclusion
Girish Badrinath Mahajan's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to impact the development of effective treatments for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile